Risk Factors for Severe Hyperbilirubinemia among Infants with Borderline Bilirubin Levels: A Nested Case-Control Study

Journal of Pediatrics

Volumn 153, Issue 2, 2008, Pages 234-240

  Kuzniewicz, Michael W ^a,c   Escobar, Gabriel J ^c,d   Wi, Soora ^c   Liljestrand, Petra ^b,c   McCulloch, Charles ^b   Newman, Thomas B ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; BREAST FEEDING; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PHOTOTHERAPY; PRIORITY JOURNAL; RISK FACTOR; SKIN BRUISING;

BILIRUBIN; CALIFORNIA; CASE-CONTROL STUDIES; ECCHYMOSIS; FEMALE; GESTATIONAL AGE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; MALE; PHOTOTHERAPY; RISK ASSESSMENT; TERM BIRTH; TREATMENT OUTCOME;

EID: 47049097050     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.01.028     Document Type: Article

References (24)

1. Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 (2004) 297-316
2. Atkinson L.R., Escobar G.J., Takayama J.I., and Newman T.B. Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline?. Pediatrics 111 (2003) e555-e561
3. Plastino R., Buchner D.M., and Wagner E.H. Impact of eligibility criteria on phototherapy program size and cost. Pediatrics 85 (1990) 796-800
4. Kemper K., Forsyth B., and McCarthy P. Jaundice, terminating breast-feeding, and the vulnerable child. Pediatrics 84 (1989) 773-778
5. American Academy of Pediatrics, and Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter management of hyperbilirubinemia in the healthy term newborn. Pediatrics 94 (1994) 558-565
6. Kemper K.J., Forsyth B.W., and McCarthy P.L. Persistent perceptions of vulnerability following neonatal jaundice. Am J Dis Child 144 (1990) 238-241
7. Hannon P.R., Willis S.K., and Scrimshaw S.C. Persistence of maternal concerns surrounding neonatal jaundice: an exploratory study. Arch Pediatr Adolesc Med 155 (2001) 1357-1363
8. Carbonell X., Botet F., Figueras J., and Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr 90 (2001) 166-170
9. Seidman D.S., Ergaz Z., Paz I., Laor A., Revel-Vilk S., Stevenson D.K., et al. Predicting the risk of jaundice in full-term healthy newborns: a prospective population-based study. J Perinatol 19 (1999) 564-567
10. Sarici S.U., Yurdakok M., Serdar M.A., Oran O., Erdem G., Tekinalp G., et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics 109 (2002) e53
11. Newman T.B., Xiong B., Gonzales V.M., and Escobar G.J. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154 (2000) 1140-1147
12. Brown A., Kim M., Wu P., and Bryla D. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 75 (1985) 393-400
13. John E. Phototherapy in neonatal hyperbilirubinaemia. Aust Paediatr J 11 (1975) 49-52
14. Martinez J.C., Maisels M.J., Otheguy L., Garcia H., Savorani M., Mogni B., et al. Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions. Pediatrics 91 (1993) 470-473
15. Newman T.B., Liljestrand P., Jeremy R.J., Ferriero D.M., Wu Y.W., Hudes E.S., et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354 (2006) 1889-1900
16. Escobar G.J., Greene J.D., Hulac P., Kincannon E., Bischoff K., Gardner M.N., et al. Rehospitalisation after birth hospitalisation: patterns among infants of all gestations. Arch Dis Child 90 (2005) 125-131
17. Escobar G.J., Li D.K., Armstrong M.A., Gardner M.N., Folck B.F., Verdi J.E., et al. Neonatal sepsis workups in infants ≥ 2000 g at birth: a population-based study. Pediatrics 106 (2000) 256-263
18. In: Iezzoni L.I. (Ed). Risk Adjustment for Measuring Healthcare Outcomes. 3rd edition (1997), Health Administration Press, Chicago
19. Kadakol A., Sappal B.S., Ghosh S.S., Lowenheim M., Chowdhury A., Chowdhury S., et al. Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus. J Med Genet 38 (2001) 244-249
20. Kaplan M., Hammerman C., and Maisels M.J. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics 111 (2003) 886-893
21. Watchko J.F., Daood M.J., and Biniwale M. Understanding neonatal hyperbilirubinaemia in the era of genomics. Semin Neonatol 7 (2002) 143-152
22. Brown A.K., Kim M.H., Wu P.Y., and Bryla D.A. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 75 (1985) 393-400
23. Boo N.Y., and Lee H.T. Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinaemia. J Paediatr Child Health 38 (2002) 151-155
24. Mehta S., Kumar P., and Narang A. A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr 147 (2005) 781-785